|Original Risk Category||PF5 + RHI Low Risk||PF5 + RHI Intermediate Risk||PF5 + RHI High Risk|
|Patients without cardiovascular events|
|PF5 low risk||59||13||1|
|PF5 intermediate risk||44||80||14|
|PF5 high risk||0||7||43|
|Patients with cardiovascular events|
|PF5 low risk||3||8||0|
|PF5 intermediate risk||5||10||3|
|PF5 high risk||0||0||30|
According to the risk of PF5 for cardiovascular events during the follow-up period (20 months), low risk indicates a risk <10%, intermediate risk indicates a risk of 10% to 20%, and high risk indicates a risk of >20%. The NRI was 8.8% (23 of 261 patients) for patients without cardiovascular events, 10.2% (6 of 59 patients) for those with cardiovascular events, and 19.0% overall.
Abbreviations as in Tables 1, 2 and 4.